Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF9906/02
CompoundFaxeladol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titleA randomized, multi-center, double blind, parallel-group study assessing the analgesic efficacy and safety of different dosages of GRT0151Y BID compared to active comparator BID and placebo BID in subjects with chronic knee-joint osteoarthritis
IndicationPolyneuropathy
UTN
CTG ID
CTIS ID (former EudraCT)2005-001404-40
Trial statusCompleted
FPINovember 8, 2005
LPOAugust 9, 2006
CountriesAustria,  Poland,  Spain
GenderAll
Age18 Years to 75 Years
ResultsYes
Pubmed
Documents
KF9906-02 | Grünenthal